Health Insurance (Section 3C Pathology Services – Cystic fibrosis gene testing) Amendment Determination 2019 (Cth)

Health Insurance (Section 3C Pathology Services – Cystic fibrosis gene testing) Amendment Determination 2019

I, Renaye Lucchese, delegate of the Minister for Health, make the following determination.

Dated   18 November 2019                             

Renaye Lucchese

A/g Assistant Secretary

Diagnostic Imaging and Pathology Branch

Medical Benefits Division

Health Financing Group

Department of Health

Contents

1  Name........................................................................................................................................ 1

2  Commencement........................................................................................................................ 1

3  Authority.................................................................................................................................. 1

4  Schedules................................................................................................................................. 1

Schedule 1— Amendments  2

1  Name

This instrument is the Health Insurance (Section 3C Pathology Services – Cystic fibrosis gene testing) Amendment Determination 2019.

2  Commencement

1. Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Commencement information
Column 1	Column 2	Column 3
Provisions	Commencement	Date/Details
1.  The whole of this instrument	1 January 2020

1. Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

This instrument is made under subsection 3C(1) of the Health Insurance Act 1973.

4  Schedules

Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1— Amendments

Health Insurance (Section 3C Pathology Services – Cystic fibrosis gene testing) Determination 2018

1. Schedule 1 (item 73348, column 2)

Omit “when requested by a specialist or consultant physician who manages the treatment of the patient”.